封面
市場調查報告書
商品編碼
1775449

全球手術器材市場:2025-2030 年預測

Global Surgical Instruments Market - Forecasts from 2025 to 2030

出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 140 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計手術器械市場規模將從 2025 年的 228.37 億美元成長到 2030 年的 331.54 億美元,複合年成長率為 7.74%。

心血管疾病盛行率高

冠心病和風濕性心臟疾病等心血管心臟疾病是外科器械需求的主要驅動力。這些疾病需要先進的外科手術干預,例如血管成形術、心臟瓣膜置換術和冠狀動脈繞道手術術,而這些手術高度依賴專用器械。隨著醫療保健系統優先考慮有效的治療方法以改善患者的預後和生活品質,這些疾病的全球負擔正在推動市場成長。

世界人口老化

老年人口的快速成長對市場擴張做出了巨大貢獻。與老齡化相關的疾病,尤其是心血管疾病,通常需要手術干預,這增加了對手術器械的需求。這種人口趨勢給醫療保健系統帶來了採用先進手術技術的壓力,進一步推動了預測期內的市場成長。

微創手術的興起

微創手術 (MIS) 的採用是主要的成長動力,包括機器人手術和非機器人手術。經皮冠狀動脈介入治療 (PCI)、球囊血管成形術和雷射血管成形術等 MIS 手術利用導管、球囊導管和支架等專用器械來治療動脈阻塞等疾病。與傳統的開放性手術相比,這些手術可實現更快的恢復、更短的住院時間、最小的疤痕和更少的術後併發症。例如,微創冠狀動脈繞道手術術和用於治療心律不整的射頻消融術採用小切口和基於導管的方法,使患者能夠快速恢復日常活動。對 MIS 的日益成長的偏好正在推動手術器械的銷售,創造永續的市場機會。

緊急情況增加

全球道路交通事故數量的不斷增加,導致緊急外科手術數量激增,進一步推動了對手術器械的需求。創傷病例通常需要即時進行手術干預,這增加了對先進器械的需求,以有效治療嚴重損傷。

外科手術的進展

外科手術技術的進步正在改變市場,使其能夠更快、更有效率地完成手術,並改善治療效果。動脈粥狀硬化斑塊切除術狀硬化斑塊切除術(使用配備刮除器的旋轉導管去除動脈斑塊)和心肌血運重組(TMR)等手術都依賴尖端儀器。同樣,心臟瓣膜置換術和心律調節器植入術也變得更加精準,從而減少了併發症並提高了患者的生活品質。這些進步推動了對專用手術器械的需求,從而支持了市場的成長。

區域洞察

北美佔據主要市場佔有率,這得益於美國高昂的醫療支出和其先進的醫療設施。該地區強大的醫療基礎設施支持先進外科技術的採用。另一方面,亞太地區是成長最快的市場之一,因為該地區需要外科手術介入的慢性疾病發生率很高。該地區各國正在投資改善醫療保健,進一步推動了對手術器材的需求。

市場挑戰

器械相關感染是市場成長的顯著限制因素。導管相關感染疾病雖然罕見,但可能嚴重且難以治療,尤其對於接受血管成形術和心導管插入術等手術的患者。免疫力較弱的患者和需要多次手術的患者發生手術部位感染等併發症的風險更高。此類擔憂需要採取嚴格的感染控制措施,這可能導致成本增加和器械核准延遲,對市場成長產生一定影響。

結論

預計到2028年,手術器械市場將迎來強勁成長,這得益於心血管疾病盛行率的上升、人口老化以及微創和先進外科手術的日益普及。北美和亞太地區是主要的成長地區,這得益於強勁的醫療保健投資和疾病的流行。然而,與器械相關感染相關的挑戰需要謹慎管理才能維持市場動能。產業參與者必須專注於技術創新和感染控制,才能抓住日益成長的手術器械需求。

本報告的主要優點

  • 深刻分析:獲得涵蓋主要和新興地區的深入市場洞察,重點關注客戶群、政府政策和社會經濟因素、消費者偏好、垂直行業和其他細分市場。
  • 競爭格局:了解全球主要企業所採用的策略策略,並了解正確策略帶來的潛在市場滲透。
  • 市場趨勢和促進因素:探索動態因素和關鍵市場趨勢以及它們將如何影響未來的市場發展。
  • 可行的建議:利用洞察力進行策略決策,在動態環境中開闢新的業務流和收益。
  • 受眾範圍廣泛:對於新興企業、研究機構、顧問公司、中小企業和大型企業都有益且具有成本效益。

它有什麼用途?

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本支出決策、監管影響、新產品開發、競爭情報

研究範圍

  • 2022 年至 2024 年的歷史數據和 2025 年至 2030 年的預測數據
  • 成長機會、挑戰、供應鏈前景、法律規範與趨勢分析
  • 競爭定位、策略和市場佔有率分析
  • 收益成長和預測包括國家在內的細分市場和地區分析
  • 公司概況(特別是財務狀況和關鍵發展)

目錄

第1章執行摘要

第2章市場概述

  • 市場概覽
  • 市場定義
  • 研究範圍
  • 市場區隔

第3章 商業景氣

  • 市場促進因素
  • 市場限制
  • 市場機會
  • 波特五力分析
  • 產業價值鏈分析
  • 政策法規
  • 策略建議

第4章 技術展望

第5章。按手術類型分類的手術器械市場

  • 介紹
  • 開放性手術
  • 微創手術
  • 機器人手術
  • 非機器人(內視鏡)手術

第6章 手術器械市場:依產品

  • 介紹
  • 手術縫合線和縫合釘
  • 手持式手術器械
  • 電外科設備
  • 其他手術設備

第7章 手術器械市場:依手術程序

  • 介紹
  • 白內障手術
  • 心血管手術
  • 剖腹產
  • 背痛手術
  • 其他

第8章 手術器械市場(依最終用戶)

  • 介紹
  • 醫院
  • 門診手術中心
  • 專科診所
  • 生命科學與生物醫學研究組織

第9章 手術器械市場(按地區)

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 西班牙
    • 義大利
    • 其他
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳洲
    • 其他

第10章競爭格局及分析

  • 主要企業和策略分析
  • 市場佔有率分析
  • 合併、收購、協議和合作
  • 競爭儀錶板

第11章 公司簡介

  • Medtronic plc
  • Johnson & Johnson
  • Stryker Corporation
  • Intuitive Surgical, Inc.
  • Boston Scientific Corporation
  • B. Braun Melsungen AG
  • Zimmer Biomet Holdings, Inc.
  • Becton, Dickinson and Company
  • CONMED Corporation
  • Olympus Corporation

第12章 附錄

  • 貨幣
  • 先決條件
  • 基準年和預測年時間表
  • 相關人員的主要利益
  • 調查方法
  • 簡稱
簡介目錄
Product Code: KSI061613459

The Global Surgical Instruments Market is expected to grow from USD 22.837 billion in 2025 to USD 33.154 billion in 2030, at a CAGR of 7.74%.

High Prevalence of Cardiovascular Diseases

Cardiovascular diseases, including coronary heart disease and rheumatic heart disease, are a primary driver of demand for surgical instruments. These conditions necessitate advanced surgical interventions, such as angioplasty, heart valve replacement, and coronary artery bypass grafts, which rely heavily on specialized instruments. The global burden of these diseases fuels market growth, as healthcare systems prioritize effective treatments to improve patient outcomes and quality of life.

Aging Global Population

The rapidly growing geriatric population significantly contributes to market expansion. Age-related diseases, particularly cardiovascular conditions, often require surgical interventions, increasing the demand for surgical instruments. This demographic trend places pressure on healthcare systems to adopt advanced surgical technologies, further driving market growth over the forecast period.

Rise in Minimally Invasive Surgeries

The adoption of minimally invasive surgeries (MIS) is a major growth driver, encompassing both robotic and non-robotic procedures. MIS techniques, such as percutaneous coronary intervention (PCI), balloon angioplasty, and laser angioplasty, utilize specialized instruments like catheters, balloon catheters, and stents to treat conditions like arterial blockages. These procedures offer faster recovery times, reduced hospital stays, minimal scarring, and lower post-surgical complications compared to traditional open surgeries. For instance, minimally invasive coronary artery bypass grafts and radiofrequency ablation for arrhythmias use small incisions or catheter-based approaches, enabling patients to resume daily activities quickly. The growing preference for MIS is boosting sales of surgical instruments, creating sustainable market opportunities.

Increase in Emergency Cases

The rising number of road accidents globally has led to a surge in emergency surgical procedures, further propelling demand for surgical instruments. Trauma cases often require immediate surgical intervention, driving the need for advanced tools to address critical injuries effectively.

Advancements in Surgical Procedures

Technological advancements in surgical techniques are transforming the market by enabling faster, more efficient procedures with improved outcomes. Procedures like atherectomy, which uses a catheter with a rotating shaver to remove arterial plaques, and transmyocardial revascularization (TMR), which employs laser beams to treat severe angina, rely on cutting-edge instruments. Similarly, heart valve replacement surgeries and pacemaker implantations have become more precise, reducing complications and enhancing patient quality of life. These advancements drive demand for specialized surgical instruments, supporting market growth.

Regional Insights

North America holds a significant market share, driven by high healthcare expenditure in the United States and access to state-of-the-art facilities. The region's robust healthcare infrastructure supports the adoption of advanced surgical technologies. Meanwhile, the Asia-Pacific region is among the fastest-growing markets due to the high prevalence of chronic diseases requiring surgical intervention. Countries in this region are investing in healthcare improvements, further fueling demand for surgical instruments.

Market Challenges

Device-associated infections pose a notable restraint on market growth. Catheter-related infections, though rare, can be severe and difficult to treat, particularly in patients undergoing procedures like angioplasty or cardiac catheterization. Patients with weakened immune systems or those requiring multiple surgeries are at higher risk of complications, such as surgical-site infections. These concerns necessitate stringent infection control measures, which can increase costs and delay device approvals, moderately impacting market growth.

Conclusion

The surgical instruments market is set for robust growth through 2028, driven by the rising prevalence of cardiovascular diseases, an aging population, and the increasing adoption of minimally invasive and advanced surgical procedures. North America and Asia-Pacific are key growth regions, supported by strong healthcare investments and disease prevalence. However, challenges related to device-associated infections require careful management to sustain market momentum. Industry players must focus on innovation and infection control to capitalize on the growing demand for surgical instruments.

Key Benefits of this Report:

  • Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
  • Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
  • Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
  • Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
  • Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

  • Historical data from 2022 to 2024 & forecast data from 2025 to 2030
  • Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
  • Competitive Positioning, Strategies, and Market Share Analysis
  • Revenue Growth and Forecast Assessment of segments and regions including countries
  • Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

By Surgery Type

  • Open Surgery
  • Minimally Invasive Surgery
  • Robotic Surgery
  • Non-Robotic (Endoscopic) Surgery

By Product

  • Surgical sutures and staples
  • Hand-held surgical devices
  • Electrosurgical devices
  • Other Surgical Devices

By Surgical Procedure

  • Cataract Surgery
  • Heart Surgery
  • Caesarean Section
  • Low Back Pain Surgery
  • Others

By End User

  • Hospital
  • Ambulatory Surgical Center
  • Specialized Clinic
  • Life Sciences and Biomedical Research Organization

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • Others
  • Middle East and Africa
  • UAE
  • Israel
  • Saudi Arabia
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Indonesia
  • Thailand
  • Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

  • 2.1. Market Overview
  • 2.2. Market Definition
  • 2.3. Scope of the Study
  • 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Porter's Five Forces Analysis
  • 3.5. Industry Value Chain Analysis
  • 3.6. Policies and Regulations
  • 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. SURGICAL INSTRUMENTS MARKET BY SURGERY TYPE

  • 5.1. Introduction
  • 5.2. Open Surgery
  • 5.3. Minimally Invasive Surgery
  • 5.4. Robotic Surgery
  • 5.5. Non-Robotic (Endoscopic) Surgery

6. SURGICAL INSTRUMENTS MARKET BY PRODUCT

  • 6.1. Introduction
  • 6.2. Surgical sutures and staples
  • 6.3. Hand-held surgical devices
  • 6.4. Electrosurgical devices
  • 6.5. Other Surgical Devices

7. SURGICAL INSTRUMENTS MARKET BY SURGICAL PROCEDURE

  • 7.1. Introduction
  • 7.2. Cataract Surgery
  • 7.3. Heart Surgery
  • 7.4. Caesarean Section
  • 7.5. Low Back Pain Surgery
  • 7.6. Others

8. SURGICAL INSTRUMENTS MARKET BY END-USER

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Ambulatory Surgical Center
  • 8.4. Specialized Clinic
  • 8.5. Life Sciences and Biomedical Research Organization

9. SURGICAL INSTRUMENTS MARKET BY GEOGRAPHY

  • 9.1. Introduction
  • 9.2. North America
    • 9.2.1. USA
    • 9.2.2. Canada
    • 9.2.3. Mexico
  • 9.3. South America
    • 9.3.1. Brazil
    • 9.3.2. Argentina
    • 9.3.3. Others
  • 9.4. Europe
    • 9.4.1. Germany
    • 9.4.2. France
    • 9.4.3. United Kingdom
    • 9.4.4. Spain
    • 9.4.5. Italy
    • 9.4.6. Others
  • 9.5. Middle East and Africa
    • 9.5.1. Saudi Arabia
    • 9.5.2. UAE
    • 9.5.3. Others
  • 9.6. Asia Pacific
    • 9.6.1. China
    • 9.6.2. India
    • 9.6.3. Japan
    • 9.6.4. Australia
    • 9.6.5. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 10.1. Major Players and Strategy Analysis
  • 10.2. Market Share Analysis
  • 10.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 10.4. Competitive Dashboard

11. COMPANY PROFILES

  • 11.1. Medtronic plc
  • 11.2. Johnson & Johnson
  • 11.3. Stryker Corporation
  • 11.4. Intuitive Surgical, Inc.
  • 11.5. Boston Scientific Corporation
  • 11.6. B. Braun Melsungen AG
  • 11.7. Zimmer Biomet Holdings, Inc.
  • 11.8. Becton, Dickinson and Company
  • 11.9. CONMED Corporation
  • 11.10. Olympus Corporation

12. APPENDIX

  • 12.1. Currency
  • 12.2. Assumptions
  • 12.3. Base and Forecast Years Timeline
  • 12.4. Key benefits for the stakeholders
  • 12.5. Research Methodology
  • 12.6. Abbreviations